SNS is implanted. Early success shows remission! Scroll to bottom of article for enrollment info.
For article go to:
From the article:
Who is eligible for the trial?
Patients who have active disease — We're enrolling patients with both Crohn's disease and ulcerative colitis between the age of 18 and 75.
What are the primary outcomes you’re hoping to achieve?
We are hoping to achieve remission.